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Identity 




The EPS8 gene can be found on chromosome 12 at 
12p12.3, starting at position 15664342 bp and ending at 
15833601 bp from pter on the reverse strand. It 
contains 21 exons. 
Transcription 




822 amino acids; contains pleckstrin homology (PH) 
domain at amino acids 69-129 and 381-414; contains 
Src homology (SH3) domain at amino acids 531-590; 
intertwined dimer. 
Expression 
Ubiquitous in adult; temporal expression in developing 
mouse embryo, in frontonasal neural crest cells, 
branchial arches, liver primordium, central nervous 
system and submandibular glands. 
Localisation 
Plasma membrane; cytoplasm; perinuclear; possibly 
nuclear. 
Function 
Scaffolding protein; participates in signal transduction 
downstream of receptor tyrosine kinases (incl. EGFR, 
CSF1R, PDGFR); receptor endocytosis; cell motility; 
actin reorganization. 
Homology 
45 orthologues identified (Ensembl). 
3 paralogues: EPS8L1; EPS8L2; EPS8L3. 
 
Schematic representation of Homo sapiens EPS8. 
 










Eps8 is reported to be expressed at elevated levels in a 
range of human malignancies, including breast cancer, 
pancreatic cancer, colon cancer and head and neck 
squamous cell carcinoma. 
Oncogenesis 
Overexpression of EPS8 has been reported to be 
sufficient to transform non-tumorigenic human cells to 
a tumorigenic phenotype. In a model system using 
murine fibroblasts, EPS8 overexpression led to 
enhanced mitogenic signaling and growth factor-
dependent cellular transformation. Constitutive tyrosine 
phosphorylation of EPS8 has been documented in 
human tumor cell lines, although the significance of 
this for tumorigenesis remains to be established. 
Breast cancer 
Oncogenesis 
EPS8 overexpression has been shown via integrated 
cDNA array comparative genomic hybridization and 
serial analyses of gene expression in a number of 
human breast cancer cell lines such as ductal carcinoma 
in situ cell lines, invasive ductal carcinomas and lymph 




EPS8 was found to be overexpressed in multiple 
pancreatic tumors, with elevated levels primarily found 
in pancreatic ductal cells, cell lines derived from 
malignancies and ascites compared to lower levels in 
primary tumors and normal pancreatic tissues. EPS8 
was reported to localize to the tips of F-actin filaments, 
filopodia, and the leading edge of the cells, and was 




EPS8 was found to be overexpressed in the majority of 
colorectal tumors compared to their normal 
counterparts. It was also found to modulate FAK 
expression and together, EPS8 and FAK were found to 
play an important role in cell locomotion. 
Head and neck squamous cell 
carcinoma 
Oncogenesis 
Greater expression of EPS8 was found in malignant 
head and neck squamous cell carcinoma cell lines 
(HN12) compared to the primary tumor derived cells 
(HN4) from the same patient. Ectopic overexpression 
of EPS8 in HN4 cells led to increased cell proliferation 
and migration in vitro and tumorgenicity in vivo.  
 
Signaling processes involving EPS8. Dashed lines, direct protein interactions; blue circles, effector proteins. 
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Knockdown of EPS8 in HN12 cells led to reduced 
migration in vitro and reduced tumorgenicity in vivo. 
EPS8 was found to mediate alphavbeta6 and 
alpha5beta1 integrin dependent activation of Rac1 and 
resulting cell migration. Suppression of either EPS8 or 
Rac1 resulted in reduced cell motility of the same 
tumor cells, however constitutive expression of Rac1 
rescued reduced cell migration in EPS8 knockdown 
cells. Therefore EPS8 and Rac1 likely modulate 
integrin-dependent tumor cell motility. FOXM1, a cell 
cycle related transcription factor, was found to be 
upregulated in tumor cells with elevated EPS8. Further 
studies showed cell proliferation and migration due to 
EPS8 occurs in part by FOXM1 deregulation and 
induction of CXC-chemokine expression, which is 
mediated by PI3K and AKT-dependent mechanisms. 
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